Edwards Lifesciences (EW) Stock Analysis: AI Score & Alternative Data
EW alt-data: revenue climbing, job postings lagging
Is Edwards Lifesciences a buy right now? The alternative data says hold. This EW stock analysis is built on the 25+ alternative data signals AltIndex tracks on Edwards Lifesciences every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 45/100: a Hold. The stock trades at $91.60 with a $53B market cap.
The bullish side of the 90-day ledger: revenue up 13.7% YoY to $1.7B. The drag: job postings down 15.0% to 494 open roles. That tension is what keeps the score mid-range.
EW’s broader alt-data profile also covers headcount (14K employees, according to LinkedIn), web traffic (210K monthly visits), business outlook (63% of employees positive), and Facebook followers (20K). Every signal links to its own page with full history, the EW technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on EW is just below.
Edwards Lifesciences AI Stock Analysis
Edwards Lifesciences Corporation is a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. The company is dedicated to providing innovative solutions that enhance lives and provide better patient outcomes.
Analysis generated August 3, 2026.
Recent Edwards Lifesciences Stock Alerts
|
Edwards Lifesciences | August 1 Over the past few months, there has been a noticeable downward trend in Instagram Followers. |
|
Edwards Lifesciences | July 30 Insider Alert: Markowitz Wayne is selling shares |
|
Edwards Lifesciences | July 28 Business Outlook among employees is down by 4.6% over the last month. |
|
Edwards Lifesciences | July 7 Job postings are down by 18.6% in the last couple of days. |
Edwards Lifesciences Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 210K | 3.4% | |
| Job Posts | 494 | 15.0% | |
| LinkedIn Employees | 14K | 2.4% | |
| Employee Recommend | 72 | 2.9% | |
| Business Outlook | 63 | 3.1% | |
| Lobbying Cost | $117K | 0% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 1 | 88.9% | |
| Stocktwits Mentions | 4 | 300.0% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 5K | 0% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 11K | 0% | |
| Instagram Followers | 4K | 1.0% | |
| Youtube Subscribers | 3K | 2.8% | |
| Facebook Followers | 20K | 2.9% | |
| Facebook Engagement | 231 | 48.7% |
About Edwards Lifesciences (EW)
Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.
| Price | $91.60 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $53B |
| Year Range | $73 – $95 |
| Dividend Yield | 0% |
| PE Ratio | 54.5 |
| Analyst Rating | 38% buy |
| Industry | Medical Devices |
Latest Edwards Lifesciences News
View more → |
Is Wall Street Bullish or Bearish on Edwards Lifesciences Stock?August 12 - Biztoc.com |
Edwards Lifesciences (EW) Has a Growth Runway Competitors May Struggle to MatchAugust 4 - Yahoo Entertainment |
|
 |
Edwards Lifesciences (EW) Stock Looks Fair On Cash Flow While Earnings Trade At A PremiumJuly 24 - Biztoc.com |
 |
Edwards Lifesciences Narrows Full-Year Sales Outlook After Second-Quarter GrowthJuly 23 - Biztoc.com |
|
Heart-Valve Maker Edwards Lifesciences Launches On Beat-And-Raise Second QuarterJuly 23 - Biztoc.com |
Edwards Lifesciences Earnings & Financial Performance
View all earnings →Edwards Lifesciences Insider Trading Activity
View all →| Markowitz Wayne filed to sell 21,534 shares at $0.0. Jul 30 '26 |
| Markowitz Wayne filed to sell 21,680 shares at $0.0. Jul 28 '26 |
| Lippis Daniel J. filed to sell 40,034 shares at $0.0. Jul 10 '26 |
| Zovighian Bernard J filed to sell 11,517 shares at $0.0. Jun 17 '26 |
| Dahl Andrew M. filed to sell 15,334 shares at $0.0. May 29 '26 |
Edwards Lifesciences Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Ro Khanna |
Jun 11, 26 | Buy | $8K+ |
| Josh Gottheimer |
Dec 30, 25 | Sell | $8K+ |
| Bruce Westerman |
May 13, 25 | Sell | $8K+ |
| Jefferson Shreve |
May 9, 25 | Buy | $33K+ |
| Rob Bresnahan |
May 8, 25 | Buy | $8K+ |
Stocks Similar to Edwards Lifesciences
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Becton Dickinson and CoBDX |
$183.40 0.8% | $50B | 57 |
 |
Agilent TechnologiesA |
$148.53 0.5% | $42B | 57 |
 |
DexcomDXCM |
$89.75 1.9% | $34B | 53 |
 |
GE HealthCareGEHC |
$73.69 0.1% | $33B | 70 |
 |
ResmedRMD |
$224.46 1.0% | $33B | 60 |
Explore Edwards Lifesciences Data
Frequently Asked Questions: Edwards Lifesciences (EW)
Edwards Lifesciences has an AltIndex AI Score of 45/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
45/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Edwards Lifesciences (EW) stock is $91.60 with a market cap of $53B.
As of today, Edwards Lifesciences’s PE (Price to Earnings) ratio is 54.5.
View the latest Edwards Lifesciences insider transactions to see recent buying and selling activity by company executives and directors.
Check the Edwards Lifesciences congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The EW stock price chart above shows Edwards Lifesciences’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Edwards Lifesciences technical analysis for RSI, moving averages, and more.
See the stocks similar to Edwards Lifesciences section on this page for companies in the same industry ranked by market cap and AI Score.
